TAG:
digital pathology
Paige’s Digital AI Tool Aids in Prostate Cancer Diagnosis
By Robert Michel | From the Volume XXVIII, No. 13 – September 27, 2021 Issue
CEO SUMMARY: Study data provided to the FDA “demonstrated increased diagnostic accuracy” when pathologists used the Paige Prostate system, said Paige’s Medical Director. The artificial intelligence-powered pathology image analysis tool is trained to help pathologists detect ev…
Digital Pathology Image Service Delivers AI via the Internet
By Robert Michel | From the Volume XXVIII, No. 13 – September 27, 2021 Issue
IN GERMANY, AN EMERGING DIGITAL PATHOLOGY (DP) COMPANY has introduced a novel feature that could be a low-cost way for pathology groups to access artificial intelligence (AI) for digital image analysis. This would appeal to pathologists who may be reluctant to invest the substantial cost and time req…
Record 600 Pathologist Jobs Open Nationwide
By Robert Michel | From the Volume XXVIII, No. 11 – August 16, 2021 Issue
CEO SUMMARY: Demand for top-level pathologists is surging. A strong rise in the number of job openings for pathologists results from a combination of factors, some related to COVID-19. Now that physicians are seeing patients again, the number of specimens has risen after falling las…
India’s Neuberg Diagnostics Expands into U.S. Market
By Robert Michel | From the Volume XXVIII, No. 11 – August 16, 2021 Issue
“Our idea is to enhance the access and affordability for next-generation techniques, meaning molecular diagnostics, genomics, pathology, digital pathology, proteomics, metabolomics, and all that. This is the spirit behind Neuberg Diagnostics. —GSK Velu, PhD, BPharm …
Genetic Testing Continues to Grow in Volume and Complexity
By Robert Michel | From the Volume XXVIII, No. 10 – July 26, 2021 Issue
This is an excerpt of a 1,333-word article in the July 26, 2021 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: Getting paid for genetic testing continues to be a challenge. This is true for both payers and the…
Artificial Intelligence Is Ready to Deliver for Labs
By Robert Michel | From the Volume XXVIII, No. 10 – July 26, 2021 Issue
CEO SUMMARY: Artificial intelligence (AI) may be one of the most over-used terms to describe a host of different applications, software tools, and products. However, during the past year, some truly revolutionary digital tools are now in use by a small number of innovative clinical laboratories…
Lab Briefs
By Robert Michel | From the Volume XXVIII, No. 7 – May 24, 2021 Issue
University of Miami Settles Lab Qui Tam Lawsuit for $22 Million EARLIER THIS MONTH, THE FEDERAL DEPARTMENT OF JUSTICE (DOJ) announced a settlement with the University of Miami that resolves allegations that the university ordered medicall…
BioReference Labs to Use Gestalt for Digital Pathology
By Robert Michel | From the Volume XXVIII, No. 6 – May 3, 2021 Issue
ONE OF THE NATION’S LARGEST CLINICAL LABORATORIEScis moving forward with plans to expand its use of digital pathology and whole-slide imaging. On Mar. 30, it was announced that BioReference Laboratories, Inc. would move forward with Gestalt Diagnostics’ PathFlow digital pathology solu…
Proscia Lands Major Deals as Digital Pathology Demand Grows
By Robert Michel | From the Volume XXVIII, No. 2 – February 8, 2021 Issue
EVEN AS THE WORLDWIDE COVID-19 PANDEMIC DERAILED SOME INDUSTRIES, it gave a major boost to digital pathology. That has meant an expanding market for Proscia, a seven-year-old provider of digital and computational pathology solutions. Established in 2014, Proscia recently won …
Digital Pathology Launched in the ‘Era of COVID-19’
By Robert Michel | From the Volume XXVIII, No. 1 – January 19, 2021 Issue
CEO SUMMARY: Is it smart to initiate digital pathology (DP) systems and whole-slide imaging just as a novel coronavirus upends healthcare and society at large? That was the question asked at Poplar Healthcare, a pathology lab in Memphis. Senior management proceeded with the implemen…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized